TP-CSO: A Triptolide Prodrug for Pancreatic Cancer Treatment

Wang, Xinlong; Zhu, Xin; Xu, Duanjie; Tian, Qikang; Wang, Can; Zhao, Lei; Zhao, Junwei; Miao, Mingsan; Wu, Xiangxiang

doi:10.3390/molecules27123686

Cited by 2 publications

(1 citation statement)

References 25 publications

(24 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It can also be modified as prodrug. Chitosan oligosaccharide (CSO) conjugated triptolide could improve the water solubility to 15 mg/ml) ( Wang et al, 2022b ). Triptolide could also be conjugated with 2-(pyridin-2-yldisul-fanyl)ethyl acrylate (PDA)- poly (ethylene glycol) methyl (PEG) and lactobionic acid (LBA) ( Sui et al, 2021 ).…”

Section: Natural Products Undergoing Clinical Evaluation In Pancreati...mentioning

confidence: 99%

The therapeutic potential of natural products for treating pancreatic cancer

Wang

Zhang

et al. 2022

Front. Pharmacol.

View full text Add to dashboard Cite

Pancreatic cancer is one of the most malignant tumors of the digestive tract, with the poor prognosis and low 5-year survival rate less than 10%. Although surgical resection and chemotherapy as gemcitabine (first-line treatment) has been applied to the pancreatic cancer patients, the overall survival rates of pancreatic cancer are quite low due to drug resistance. Therefore, it is of urgent need to develop alternative strategies for its treatment. In this review, we summarized the major herbal drugs and metabolites, including curcumin, triptolide, Panax Notoginseng Saponins and their metabolites etc. These compounds with antioxidant, anti-angiogenic and anti-metastatic activities can inhibit the progression and metastasis of pancreatic cancer. Expecting to provide comprehensive information of potential natural products, our review provides valuable information and strategies for pancreatic cancer treatment.

show abstract

Section: Natural Products Undergoing Clinical Evaluation In Pancreati...mentioning

confidence: 99%

The therapeutic potential of natural products for treating pancreatic cancer

Wang

Zhang

et al. 2022

Front. Pharmacol.

View full text Add to dashboard Cite

show abstract

Therapeutic Effect of Triptolide Polymer Mesoscale Nanoparticles on Diabetic Nephropathy Mice

Guo

Peng

2023

sci adv mater

View full text Add to dashboard Cite

Triptolide (TP) has potential adoption value in the treatment of nephropathy, but its poor water solubility causes toxicity and side effects to various degrees in the kidney, liver, and other organs. In this research, TP-mesoscale nanoparticles (TP-MNPs) were synthesized by the amide reaction of poly(lactic-co-glycolic acid) (PLGA) and methoxy polyethylene glycol amine (mPEG-NH2) as drug carrier materials. The structure of TP-MNPs was characterized by 1H NMR, scanning electron microscopy (SEM), and zeta potential using a nanoparticle potential analyzer. Liquid chromatography–mass spectrometry (HPLC–MS) was utilized to determine the content of TP in TP-MNPs and calculate the entrapment rate (ER) and drug loading (DL) of TP-MNPs. The cytotoxicity of TP-MNPs was detected by CCK8. Eight mice were enrolled in Blank group (no treatment), and the other 24 model group animals were rolled into model group (DM), TP group (TP intervention), and TP-MNP group (TP-MNPs intervention) randomly, with eight mice in each group. The urine protein content, serum albumin (Alb), blood glucose (Glu), creatinine (Cre), total cholesterol (TCHO), and triglyceride (TG) contents of mice in various groups after intervention were compared. The results revealed that average diameter of MNPs was (379.6±26.44) nm, that of TP-MNPs was (424.3±56.29) nm, and average zeta potentials of TP, MNPs, and TP-MNPs were (−28.29±3.85) mV, (−15.51±1.79) mV, and (−13.45±1.81) mV, respectively. The curve changed with TP concentration. With increasing TP concentration, the ER of TP-MNPs decreased drastically, and the DL demonstrated a drastic upward trend. Furthermore, the cell activities of HK-2, NRK-52E, LO2, and AML-12 treated with TP-MNPs were higher versus TP group (P <0.05). Urine protein content, body weight, renal index, serum Glu, TCHO, and TG content in the DM group were markedly superior to Blank group (P <0.001), while urine protein content in TP-MNP group was considerably inferior to the DM group (P <0.01). Alb and Cre in the serum of mice in DM group were substantially lower versus Blank group (P <0.01), while those in TP group were lower than Blank group (P <0.05). Alb and Cre in TP-MNP group were superior to DM group (P <0.05). In summary, TP-MNPs prepared in this research had ideal biocompatibility, could effectively improve urinary protein, body weight, renal index, and serum biochemical indexes caused by DM, and had a certain therapeutic effect on diabetic nephropathy (DN) mice.

show abstract

TP-CSO: A Triptolide Prodrug for Pancreatic Cancer Treatment

Cited by 2 publications

References 25 publications

The therapeutic potential of natural products for treating pancreatic cancer

The therapeutic potential of natural products for treating pancreatic cancer

Therapeutic Effect of Triptolide Polymer Mesoscale Nanoparticles on Diabetic Nephropathy Mice

Contact Info

Product

Resources

About